Related Experiment Videos
[Autoimmune thrombocytopenias].
1Service d'hématologie adultes Hôpital Necker 75743 Paris. francois.lefrere@nck.ap-hop-paris.fr
La Revue Du Praticien
|January 5, 2002
Summary
Primary immune thrombocytopenic purpura (ITP) diagnosis and treatment remain uncertain. While often benign, severe cases require controversial therapies like IVIg or splenectomy, especially in adults.
Area of Science:
- Hematology
- Immunology
Context:
- Primary immune thrombocytopenic purpura (ITP) is a hematological disorder characterized by anti-platelet antibodies.
- Diagnosis involves excluding drug/viral causes and other autoimmune diseases like lupus.
- ITP management is challenging due to uncertain diagnostic and treatment strategies.
Purpose:
- To outline diagnostic criteria for ITP.
- To discuss current therapeutic options and controversies in ITP management.
- To differentiate ITP course and treatment in children versus adults.
Summary:
- ITP diagnosis requires peripheral thrombocytopenia after excluding other causes.
- Treatment decisions are controversial, especially for platelet counts between 20-50 x 10(9)/L.
- While children often recover spontaneously, adults may require splenectomy for chronic ITP with low platelets.
Impact:
- Highlights the need for clearer diagnostic and treatment guidelines for ITP.
- Emphasizes the cost-effectiveness debate between glucocorticoids and IVIg.
- Informs clinical practice regarding ITP management in different age groups.